COVID-19 accelerated the adoption of new decentralized clinical trial operating models and revealed the need to make studies more patient-centric. The industry is now maturing practices adopted during the pandemic into a more digital, connected model for clinical trials in the future.
This survey report details insights from more than 280 clinical leaders worldwide on the industry’s progress toward digital trial strategies, lessons learned, and what lies ahead.
Read on for a snapshot of the findings.Download the Full Report
Rapid Adoption of Decentralized Trials
eClinical Applications Used to Manage Decentralized Trials
Plans to Adopt Digital Trial Technologies in the Future
Barriers to Patient- and Site-Centric Trials
Sites are burdened by too many technologies; we need to make it simpler for them… and use fewer technologies.
Decentralized trials introduce more technology, processes, and burden for the site. We need to provide a helping hand, a white-glove approach to help them with efficient execution.
Benefits of Decentralized Trials
Advancing the Move to Digital Trials
and processes into a comprehensive digital trial strategy:
It is essential to evaluate the relative merits of technologies but aim to use fewer applications with better connections between them.
Critically evaluate solutions that optimize the sponsor, investigator, and patient experience.
Better Trials Through a Connected Ecosystem
A holistic end-to-end digital framework for clinical trials promises to meet the diverse needs of patients, sites, sponsors, and CROs, strengthens the connections between them, and reduces trial costs and timelines. As the industry progresses toward a more digital and connected way of operating, clinical trials will become more innovative, better serve patients, and speed their access to medical breakthroughs.Download the Full Report